Galapagos | GLPG - Operating Profit

Stock Price
24.42
Daily Change
0.06 0.25%
Monthly
-3.86%
Yearly
3.21%
Q2 Forecast
23.85

Galapagos reported EUR780.56M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Genmab DKK 260M 199M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Merck EUR 474M 738M Dec/2025
Neurocrine Biosciences USD 227.9M 11.4M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
UCB EUR 1.29B 571M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025